Article
Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.
Therapeutic drug monitoring - 1 Jun 2014
Inoue Kazuyuki, Suzuki Eri, Yazawa Rei, Yamamoto Yoshiaki, Takahashi Toshiki, Takahashi Yukitoshi, Imai Katsumi, Koyama Seiichi, Inoue Yushi, Tsuji Daiki, Hayashi Hideki, Itoh Kunihiko
Abstract excerpt
BACKGROUND: Valproic acid (VPA) is widely used to treat various types of epilepsy. Interindividual variability in VPA pharmacokinetics may arise from genetic polymorphisms of VPA-metabolizing enzymes. This study aimed to examine the relationships between plasma VPA concentrations and the -161C>T single nucleotide polymorphism in uridine diphosphate glucuronosyltransferase (UGT) 2B7 genes in pediatric epilepsy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
